---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-007137"
form_type: "8-K"
ticker: "DMII"
cik: "0002040475"
company_name: "Drugs Made In America Acquisition II Corp."
filed_at: "2026-11-18T16:08:56+00:00"
generated_at: "2026-11-18T16:10:07.289373+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DMII proposes $600M combination with Alpha AI Biotech paid in 60M shares at $10.00

## Summary
- Preliminary, nonbinding proposal values Alpha AI Biotech Group at $600 million pre-money, payable in 60,000,000 ordinary shares at $10.00 per share.
- Up to 30,000,000 additional earn-out shares in two equal tranches tied to share-price thresholds of $12.50 and $15.00 during 24 months after closing.
- Board approved a 30-day limited standstill expiring on or about December 3, 2026; no definitive agreement, due diligence and audited financials still pending.
- Investor Tal Alpha funded $250,000 on November 6, 2026; notes consolidated into a $700,000 convertible note maturing June 30, 2027, convertible at a 35% discount; $700,000 remains available.
- Alon Izidor Tal, CEO of the Investor, is also an Alpha director and acknowledged the proposal on Alpha's behalf.

## SEC filing metadata
- accession: 0001477932-26-007137
- form_type: 8-K
- ticker: DMII
- cik: 0002040475
- company_name: Drugs Made In America Acquisition II Corp.
- filed_at: 2026-11-18T16:08:56+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2040475/000147793226007137/0001477932-26-007137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2040475/000147793226007137/dmiiu_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-007137
- JSON: https://secwatch.observer/filing/0001477932-26-007137.json
- Plain text: https://secwatch.observer/filing/0001477932-26-007137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
